• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
water filter
WATER FILTER FOR WATER PURIFIER
DUST BAG
Small dust filter
HUMIDIFIER FILTER
Oil fume adsorption filter

Biocon launches Tacrolimus capsules in US

expresspharmaDecember 29, 2020

Tag: Biocon , Tacrolimus Capsules , US , immunosuppressant , Organ transplant

Biocon announced the launch of Tacrolimus capsules in the US. Tacrolimus, a calcineurin inhibitor, is an immunosuppressant used in the treatment of organ transplant patients, which reduces the body’s ability to reject a transplanted organ.

It has been particularly effective in treating patients of renal transplant for more than two decades.

Siddharth Mittal, CEO and MD, Biocon, said, “The launch of Tacrolimus capsules in the US is another milestone for Biocon that reflects our commitment to continually evaluate and expand our portfolio of complex products to serve patients.”


Previous:LYNPARZA (olaparib) get three new approvals in Japan

Next:Serum Institute of India launches indigenously developed pneumococcal vaccine, ‘PNEUMOSIL’

Related News

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

PharmaSourcesOctober 15, 2024

Thrombolytic Science, LLC (TSI), announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for mutant prourokinase, a recombinant fibrinolytic pro-enzyme.

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

PharmaSourcesOctober 15, 2024

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

PharmaSourcesOctober 15, 2024

Biocon launches Tacrolimus capsules in US | Pharmasources.com

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

PharmaSourcesOctober 15, 2024

BD and ten23 health today announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology.

You may like
More>>

best sustained release BCAA

best sustained release BCAA
coprinus comatus powder;shaggy mane mushroom powder

coprinus comatus powder;shaggy mane mushroom powder
Mr Berlusconi cholic acid

Mr Berlusconi cholic acid
2L Extractive distillation device(customize)

2L Extractive distillation device(customize)
business industrial Refrigeration circulator

business industrial Refrigeration circulator
CytoLinX® WB Single-Use Rocking Bioreactor

CytoLinX® WB Single-Use Rocking Bioreactor
IZS60-1A Industrial Syringe Pump

IZS60-1A Industrial Syringe Pump
QIGUI FUSHE JIAONANG

QIGUI FUSHE JIAONANG
diffusion flow test for filter integrity

diffusion flow test for filter integrity
Reishi Mushroom Extract

Reishi Mushroom Extract

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service